Science Explorer Back to mapMap
Discussion
Topic · Public Health, Environmental and Occupational Health

Streptococcal Infections and Treatments

Streptococcal Infections and Treatments is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 41k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the global burden, pathogenesis, and management of Group A Streptococcal diseases, including necrotizing fasciitis, rheumatic heart disease, and soft tissue infections. It covers topics such as streptococcal virulence factors, immunoglobulin therapy, and the epidemiology of streptococcal infections.

  • Streptococcus Pyogenes
  • Necrotizing Fasciitis
  • Rheumatic Heart Disease
  • Soft Tissue Infections
  • Pathogenesis
  • Virulence Factors
  • Pharyngitis
  • Toxins
  • Immunoglobulin Therapy
  • Epidemiology
Research works
41k
fractional, since 1950
In the world top 10%
4.2k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-1%
the tick is no change
Largest producer
United States
33% of the 10 largest, 2022-now
Streptococcal Infections and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Streptococcal Infections and Treatments research?

By volume, the United States and China publish the most (1.4k and 744 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.4k works
  2. 2 China 744 works
  3. 3 India 525 works
  4. 4 Japan 361 works
  5. 5 United Kingdom 265 works
  6. 6 Türkiye 230 works
  7. 7 Brazil 221 works
  8. 8 Spain 209 works
  9. 9 Australia 187 works
  10. 10 Italy 181 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.9%China: 17.1%India: 12.1%Japan: 8.3%6 others listed: 29.7%33%largest
United States1,430 · 32.9%China744 · 17.1%India525 · 12.1%Japan361 · 8.3%6 others listed1,293 · 29.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Streptococcal Infections and Treatments research?

By volume in 2022-now, Harvard University publishes the most Streptococcal Infections and Treatments research, followed by All India Institute of Medical Sciences and Sichuan University.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 37 works
  2. 2 All India Institute of Medical SciencesIndia 36 works
  3. 3 Sichuan UniversityChina 24 works
  4. 4 Mayo ClinicUnited States 24 works
  5. 5 Sağlık Bilimleri ÜniversitesiTürkiye 22 works
  6. 6 Baylor College of MedicineUnited States 22 works
  7. 7 The University of MelbourneAustralia 20 works
  8. 8 Centre National de la Recherche ScientifiqueFrance 18 works
  9. 9 Capital Medical UniversityChina 18 works
  10. 10 Zhejiang UniversityChina 18 works

Who are the leading researchers in Streptococcal Infections and Treatments?

The most-cited researchers publishing on Streptococcal Infections and Treatments include Christopher J L Murray, Rob Knight and Theo Vos.

  1. 1 Christopher J L Murray United States 583k citations
  2. 2 Rob Knight United States 468k citations
  3. 3 Theo Vos United States 439k citations
  4. 4 Ali H. Mokdad United States 429k citations
  5. 5 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  6. 6 Shizuo Akira Japan 342k citations
  7. 7 Gordon Henry Guyatt Canada 315k citations
  8. 8 Gregory Y.H. Lip United Kingdom 311k citations
  9. 9 Peter Jüni Switzerland 303k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Streptococcal Infections and Treatments?

The most cited paper in Streptococcal Infections and Treatments is "Acute-Phase Proteins and Other Systemic Responses to Inflammation" (Cem Gabay, Irving Kushner, 1999), with 6,808 citations. Next come "Staphylococcus aureus Infections" (6,083) and "Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management" (5,276).

Most cited papers
#PaperReleasedCitations
1 Acute-Phase Proteins and Other Systemic Responses to Inflammation Cem Gabay, Irving Kushner · New England Journal of Medicine 11 Feb 1999 6,808
2 Staphylococcus aureus Infections F D Lowy · New England Journal of Medicine 20 Aug 1998 6,083
3 Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management Steven Y. C. Tong, Joshua Saul Davis, Emily M. Eichenberger et al. · Clinical Microbiology Reviews Open access 27 May 2015 5,276
4 The NLRP3 inflammasome: molecular activation and regulation to therapeutics Karen V. Swanson, Meng Deng, Jenny P.‐Y. Ting · Nature reviews. Immunology ReviewOpen access 29 Apr 2019 4,877
5 Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · Clinical Infectious Diseases Open access 6 Jan 2011 4,237
All 99 most cited papers, with filters and sorting

Where is Streptococcal Infections and Treatments research done?

The largest centres of Streptococcal Infections and Treatments research in 2022-now are Beijing (China), Tokyo (Japan), London (United Kingdom) and Paris (France).

Largest cities, 2022-now

  1. 1 BeijingChina 100 works
  2. 2 TokyoJapan 89 works
  3. 3 LondonUnited Kingdom 79 works
  4. 4 ParisFrance 65 works
  5. 5 MadridSpain 61 works
  6. 6 IstanbulTürkiye 56 works
  7. 7 New YorkUnited States 55 works
  8. 8 MoscowRussia 52 works
  9. 9 São PauloBrazil 50 works
  10. 10 SeoulSouth Korea 44 works
See Streptococcal Infections and Treatments on the map

Where is the best place to study Streptococcal Infections and Treatments?

Among universities, judged by research, Sichuan University, Harvard University and Southern Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 24.54%fractional works in this field (log) →share of work in the world top 10% →Southern Medical Uni…Sichuan UniversityThe University of Me…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sichuan UniversityChina 74.830.0%1.7×24 +42.3%
2Harvard UniversityUnited States 65.915.5%1.9×37 -27.4%
3Southern Medical UniversityChina 63.635.6%2.9×11 +105.5%
4The University of MelbourneAustralia 58.318.7%3.0×20 -22.6%
5Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 56.227.2%1.7×11 +147.7%
6Nanjing Agricultural UniversityChina 54.224.3%5.8×14 -1.0%
7Zhejiang UniversityChina 53.819.8%1.1×18 +44.5%
8Capital Medical UniversityChina 53.319.4%2.7×18 +50.1%
9Karolinska InstitutetSweden 53.126.7%2.9×10 -28.5%
10University of Colorado DenverUnited States 52.028.2%4.4×9 +36.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Streptococcal Infections and Treatments, country by country

Is Streptococcal Infections and Treatments research growing?

Output in 2022-2025 was 1% lower than in 2018-2021, peaking in 2021.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Streptococcal Infections and Treatments as a percentage of every work published that year, 0.029% in 2024.

still counting0.020%0.040%0.060%Streptococcal Infections and Treatments0.027% in 202519801990200020102020

Fractional works of Streptococcal Infections and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Streptococcal Infections and Treatments10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Streptococcal Infections and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.